Funding search · EIN 133912580 · New York, NY

Emerald Foundation

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

64
grants reported
$3.7M
total given
2022–2024
filing years
$50,000
median grant

Based on grants this organization reported to the IRS for tax years 20222024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

cancercellsinvestigatedeveloptumorcelldeterminepdac

Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

11 grants matching “immunotherapies · $530,000

  • $87,500

    Massachusetts Institute of Technolo · Cambridge, MA · 2024

    To study how ferroptosis-based strategies can enhance the efficacy of immunotherapies in breast cancer.

  • $50,000

    John Hopkins University · Baltimore, MD · 2024

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $100,000

    John Hopkins University · Baltimore, MD · 2023

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $50,000

    John Hopkins University · Baltimore, MD · 2023

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2023

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intransigence to immunotherapies.

  • $37,500

    Whitehead Institute for Biomed · Cambridge, MA · 2023

    To study how ferroptosis-based strategies can enhance the efficacy of immunotherapies in breast cancer.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2023

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intrasigence to immunotherapies.

  • $50,000

    John Hopkins University · Baltimore, MD · 2022

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2022

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intransigence to immunotherapies.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2022

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intrasigence to immunotherapies.

  • $5,000

    John Hopkins University · Baltimore, MD · 2022

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

  • Ma Institute of Technology6 grants · $375,000
  • John Hopkins University8 grants · $367,500
  • Dana-Farber Cancer Institute3 grants · $250,000
  • University of Md Baltimore Foundati2 grants · $225,000
  • Massachusetts Institute of Technolo2 grants · $162,500
  • University of Maryland Sch of Medic2 grants · $150,000
  • Weill Med College of Cornell U1 grant · $150,000
  • Salk Institute for Bio Studies3 grants · $150,000
  • Inserm Dr Grand Ouest2 grants · $150,000
  • University of Ky2 grants · $137,500

Giving over time

$1.2M
2022
$1.2M
2023
$1.3M
2024

Grant history

All 64 reported grants, largest first.

  • $150,000

    University of Md Baltimore Foundati · Baltimore, MD · 2023

    To investigate the regulation of treg lymphatic tumor migration and the interaction among tregs, lymphatic endothelial cells, and tumors to develop strategies of delivering targeted therapies locally instead of systemic read all
  • $150,000

    Ma Institute of Technology · Cambridge, MA · 2022

    To enhance nanoparticle accumulation in desired cell types to develop more effective and safer targeted nanotherapies.

  • $150,000

    Weill Med College of Cornell U · New York, NY · 2022

    To identify regulators of lineage reversion that impact resistance to wnt-targeted therapies in colorectal cancer.

  • $100,000

    Dana-Farber Cancer Institute · Boston, MA · 2023

    To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause nk suppression, on both nk and tumor cells, using high-throughput and unbiased approaches.

  • $100,000

    Inserm Dr Grand Ouest · 2023

    To determine the mechanism through which breast cancer cell clusters dissociate into single cells and proliferate at distant sites and to determine the impact of the new environment on metastasis formation.

  • $100,000

    John Hopkins University · Baltimore, MD · 2023

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $100,000

    University of Ky · Lexington, KY · 2023

    To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function.

  • $100,000

    Dana-Farber Cancer Institute · Boston, MA · 2022

    To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause nk suppression, on both nk and tumor cells, using high-throughput and unbiased approaches.

  • $100,000

    University of Guelph · 2022

    To identify combinations of commercial bacterial isolates that suppress klebsiella pneumoniae in the colon and the underlying cooperative mechanisms of this activity.

  • $87,500

    Massachusetts Institute of Technolo · Cambridge, MA · 2024

    To study how ferroptosis-based strategies can enhance the efficacy of immunotherapies in breast cancer.

  • $80,000

    Ca Institute of Technology · Pasadena, CA · 2022

    To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes.

  • $75,000

    Massachusetts Institute of Technolo · Cambridge, MA · 2024

    To enhance nanoparticle accumulation in desired cell types to develop more effective and safer targeted nanotherapies.

  • $75,000

    Nyu School of Medicine · New York, NY · 2024

    To examine the cellular mechanisms through which dendrite-centric Alzheimer's disease pathologies result in cognitive dysfunction and hyper-excitability.

  • $75,000

    University of Maryland Sch of Medic · Baltimore, MD · 2024

    To investigate the regulation of Treg lymphatic tumor migration and the interaction among Tregs, lymphatic endothelial cells, and tumors to develop strategies of delivering targeted therapies locally instead of systemic read all
  • $75,000

    University of Maryland Sch of Medic · Baltimore, MD · 2024

    To investigate the regulation of treg lymphatic tumor migration and the interaction among tregs, lymphatic endothelial cells, and tumors to develop strategies of delivering targeted therapies locally instead of systemic read all
  • $75,000

    Weill Cornell Medicine · New York, NY · 2024

    To identify regulators of lineage reversion that impact resistance to WNT-targeted therapies in colorectal cancer.

  • $75,000

    Joan Sanford I Weill Medical · New York, NY · 2023

    To identify regulators of lineage reversion that impact resistance to wnt-targeted therapies in colorectal cancer.

  • $75,000

    Ma Institute of Technology · Cambridge, MA · 2023

    To enhance nanoparticle accumulation in desired cell types to develop more effective and safer targeted nanotherapies.

  • $75,000

    Rockefeller University · New York, NY · 2022

    To investigate the role of trna-derived fragments and the genes they regulate in breast cancer progression and metastasis.

  • $75,000

    Univeristy of Ca San Francisco · San Francisco, CA · 2022

    To develop a small molecule that stabilizes mutant p53 in cancer and further elaborate this compound with the ability to increase dna binding of bound p53.

  • $75,000

    University of Md Baltimore Foundati · Baltimore, MD · 2022

    To investigate the regulation of treg lymphatic tumor migration and the interaction among tregs, lymphatic endothelial cells, and tumors to develop strategies of delivering targeted therapies locally instead of systemic read all
  • $50,000

    Dana-Farber Cancer Institute · Boston, MA · 2024

    To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches.

  • $50,000

    Inserm Dr Grand Ouest · 2024

    To determine the mechanism through which breast cancer cell clusters dissociate into single cells and proliferate at distant sites and to determine the impact of the new environment on metastasis formation.

  • $50,000

    John Hopkins University · Baltimore, MD · 2024

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $50,000

    Salk Institute for Bio Studies · La Jolla, CA · 2024

    To use innovative cell biology techniques coupled with genomics to investigate the role of mitochondrial-derived vesicles in cancer cell metabolism.

  • $50,000

    Salk Institute for Biological Studi · La Jolla, CA · 2024

    To use innovative cell biology techniques coupled with genomics to investigate the role of mitochondrial-derived vesicles in cancer cell metabolism.

  • $50,000

    University of Kentucky · Lexington, KY · 2024

    To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function.

  • $50,000

    University of Kentucky · Lexington, KY · 2024

    To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function.

  • $50,000

    University of Michigan · Ann Arbor, MI · 2024

    To use tumor organoid and mouse models to determine how loss of Claudin proteins impacts tumor invasion and metastasis.

  • $50,000

    University of Pennsylvania · Philadelphia, PA · 2024

    To understand the molecular mechanism underlying immunosuppression and immunoactivation and develop new treatment strategies for hepatic malignancies.

  • $50,000

    Whitehead Inst for Biomedical Resea · Cambridge, MA · 2024

    To uncover the set of cell-surface proteins that mediate essential interactions between PDAC cells and their microenvironment.

  • $50,000

    Whitehead Inst for Biomedical Resea · Cambridge, MA · 2024

    To identify molecular mechanisms that help anaerobes cope with oxygen exposure and/or oxidative stress.

  • $50,000

    John Hopkins University · Baltimore, MD · 2023

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $50,000

    Salk Institute for Bio Studies · La Jolla, CA · 2023

    To use innovative cell biology techniques coupled with genomics to investigate the role of mitochondrial-derived vesicles in cancer cell metabolism.

  • $50,000

    Whitehead Institute for Biomed · Cambridge, MA · 2023

    To uncover the set of cell-surface proteins that mediate essential interactions between pdac cells and their microenvironment.

  • $50,000

    John Hopkins University · Baltimore, MD · 2022

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

  • $50,000

    Salk Institute for Bio Studies · La Jolla, CA · 2022

    To use innovative cell biology techniques coupled with genomics to investigate the role of mitochondrial-derived vesicles in cancer cell metabolism.

  • $50,000

    Whitehead Institute for Biomed · Cambridge, MA · 2022

    To uncover the set of cell-surface proteins that mediate essential interactions between pdac cells and their microenvironment.

  • $37,500

    California Insitute of Technology · Pasadena, CA · 2024

    To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes.

  • $37,500

    Fox Chase Cancer Center · Philadelphia, PA · 2024

    To investigate the role of Brg1-dependent epigenetic regulation on PDAC fibroblast pro-tumorigenic functions.

  • $37,500

    Harvard Medical School · Boston, MD · 2024

    To study how SLC7A5 regulates metabolic reprogramming and signaling pathways that enable cancer cells to survive CDK4/6i treatment.

  • $37,500

    John Hopkins University · Baltimore, MD · 2024

    To use tumor organoid and mouse models to determine how loss of claudin proteins impacts tumor invasion and metastasis.

  • $37,500

    Nyu School of Medicine · New York, NY · 2024

    To characterize interactions between proteins that associate only with the KRAS4A isoform to identifying pathways that can be rationally targeted to achieve a more comprehensive interruption of KRAS stimulation.

  • $37,500

    Weill Cornell Medicine · New York, NY · 2024

    To characterize exosomes from nave and tumor-educated platelets and determine their contribution to metastatic dormancy and recurrence.

  • $37,500

    Who We Play for · Cocoa Beach, FL · 2024

    To screen young students for previously undiagnosed heart ailments and generate data that can be used to train AI programs to better evaluate electrocardiograms.

  • $37,500

    Ca Insitute of Technology · Pasadena, CA · 2023

    To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes.

  • $37,500

    Ca Institute of Technology · Pasadena, CA · 2023

    To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes.

  • $37,500

    Institute for Cancer Research · Philadelphia, PA · 2023

    To investigate the role of brg1-dependent epigenetic regulation on pdac fibroblast pro-tumorigenic functions.

  • $37,500

    Joan Sanford I Weill Medical · New York, NY · 2023

    To characterize exosomes from nave and tumor-educated platelets and determine their contribution to metastatic dormancy and recurrence.

  • $37,500

    John Hopkins University · Baltimore, MD · 2023

    To use tumor organoid and mouse models to determine how loss of claudin proteins impacts tumor invasion and metastasis.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2023

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intransigence to immunotherapies.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2023

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intrasigence to immunotherapies.

  • $37,500

    President Fellows of Harvard · Boston, MA · 2023

    To study how slc7a5 regulates metabolic reprogramming and signaling pathways that enable cancer cells to survive cdk4/6i treatment.

  • $37,500

    Whitehead Institute for Biomed · Cambridge, MA · 2023

    To study how ferroptosis-based strategies can enhance the efficacy of immunotherapies in breast cancer.

  • $37,500

    Who We Play for · Cocoa Beach, FL · 2023

    To screen young students for previously undiagnosed heart ailments and generate data that can be used to train ai programs to better evaluate electrocardiograms.

  • $37,500

    Institute for Cancer Research · Philadelphia, PA · 2022

    To investigate the role of brg1-dependent epigenetic regulation on pdac fibroblast pro-tumorigenic functions.

  • $37,500

    John Hopkins University · Baltimore, MD · 2022

    To use tumor organoid and mouse models to determine how loss of claudin proteins impacts tumor invasion and metastasis.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2022

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intransigence to immunotherapies.

  • $37,500

    Ma Institute of Technology · Cambridge, MA · 2022

    To develop a high-throughput single-cell gro-seq assay to examine the tumor microenvironment established by mutant-p53 and decipher the gene regulatory networks underlying pdac's intrasigence to immunotherapies.

  • $37,500

    University of Ca Santa Barbara · Santa Barbara, CA · 2022

    To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function.

  • $37,500

    University of Ky · Lexington, KY · 2022

    To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function.

  • $10,000

    Cancer Research UK Cruk · 2024

    Sponsorship of CRUK conferences Sponsorship fee - Travel Bursaries for those attending the Black in Cancer Conference (2022).

  • $5,000

    Institute for Cancer Research · Philadelphia, PA · 2022

    To investigate the role of brg1-dependent epigenetic regulation on pdac fibroblast pro-tumorigenic functions.

  • $5,000

    John Hopkins University · Baltimore, MD · 2022

    To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer.

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.